UniProt ID | TLR1_HUMAN | |
---|---|---|
UniProt AC | Q15399 | |
Protein Name | Toll-like receptor 1 | |
Gene Name | TLR1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 786 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein . Cytoplasmic vesicle, phagosome membrane Single-pass type I membrane protein . Membrane raft . Golgi apparatus . Does not reside in lipid rafts before stimulation but accumulates increasingly in |
|
Protein Description | Participates in the innate immune response to microbial agents. Specifically recognizes diacylated and triacylated lipopeptides. Cooperates with TLR2 to mediate the innate immune response to bacterial lipoproteins or lipopeptides. [PubMed: 21078852 Forms the activation cluster TLR2:TLR1:CD14 in response to triacylated lipopeptides, this cluster triggers signaling from the cell surface and subsequently is targeted to the Golgi in a lipid-raft dependent pathway] | |
Protein Sequence | MTSIFHFAIIFMLILQIRIQLSEESEFLVDRSKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELGEFVKNIDQVSSEVLEGWPDSYKCDYPESYRGTLLKDFHMSELSCNITLLIVTIVATMLVLAVTVTSLCSYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSGHDSFWVKNELLPNLEKEGMQICLHERNFVPGKSIVENIITCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNSLILILLEPIPQYSIPSSYHKLKSLMARRTYLEWPKEKSKRGLFWANLRAAINIKLTEQAKK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MTSIFHFAI ------CCHHHHHHH | 30.45 | 24043423 | |
3 | Phosphorylation | -----MTSIFHFAII -----CCHHHHHHHH | 23.20 | 24043423 | |
44 | Phosphorylation | IHVPKDLSQKTTILN EECCCCHHCCCEEEE | 39.50 | - | |
48 | Phosphorylation | KDLSQKTTILNISQN CCHHCCCEEEEECHH | 30.42 | - | |
51 | N-linked_Glycosylation | SQKTTILNISQNYIS HCCCEEEEECHHHHH | 28.19 | 17889651 | |
53 | Phosphorylation | KTTILNISQNYISEL CCEEEEECHHHHHHH | 15.99 | - | |
56 | Phosphorylation | ILNISQNYISELWTS EEEECHHHHHHHHHH | 9.74 | - | |
67 | Phosphorylation | LWTSDILSLSKLRIL HHHHHHHHCCCCEEE | 30.82 | 24719451 | |
137 | N-linked_Glycosylation | PICKEFGNMSQLKFL HHHHHHCCHHHHHHC | 32.05 | UniProtKB CARBOHYD | |
148 | Phosphorylation | LKFLGLSTTHLEKSS HHHCCCCCCCCCCCC | 24.23 | 27251275 | |
149 | Phosphorylation | KFLGLSTTHLEKSSV HHCCCCCCCCCCCCC | 22.53 | 27251275 | |
154 | Phosphorylation | STTHLEKSSVLPIAH CCCCCCCCCCCCEEE | 19.12 | 22210691 | |
155 | Phosphorylation | TTHLEKSSVLPIAHL CCCCCCCCCCCEEEC | 38.45 | 22210691 | |
163 | N-linked_Glycosylation | VLPIAHLNISKVLLV CCCEEECCHHHHHHH | 26.98 | 17889651 | |
330 | N-linked_Glycosylation | FSNMNIKNFTVSGTR HHCCCCEEEEEECCE | 33.74 | 17889651 | |
416 | Methylation | SVSYDEKKGDCSWTK CCCCCCCCCCCHHHH | 58.91 | - | |
416 | Trimethylation | SVSYDEKKGDCSWTK CCCCCCCCCCCHHHH | 58.91 | - | |
420 | Phosphorylation | DEKKGDCSWTKSLLS CCCCCCCHHHHHHHC | 42.39 | - | |
422 | Phosphorylation | KKGDCSWTKSLLSLN CCCCCHHHHHHHCCC | 8.41 | - | |
429 | N-linked_Glycosylation | TKSLLSLNMSSNILT HHHHHCCCCCCCCCH | 25.55 | 17889651 | |
431 | Phosphorylation | SLLSLNMSSNILTDT HHHCCCCCCCCCHHH | 21.11 | - | |
529 | Phosphorylation | GDNPFQCTCELGEFV CCCCEEEEEEHHHHH | 9.76 | - | |
537 | Ubiquitination | CELGEFVKNIDQVSS EEHHHHHHCHHHHCH | 54.21 | - | |
578 | N-linked_Glycosylation | HMSELSCNITLLIVT CHHHHHCCCHHHHHH | 27.23 | UniProtKB CARBOHYD | |
678 | Phosphorylation | RNFVPGKSIVENIIT CCCCCCHHHHHHHHH | 37.47 | - | |
685 | Phosphorylation | SIVENIITCIEKSYK HHHHHHHHHHHHHCC | 12.02 | - | |
690 | Phosphorylation | IITCIEKSYKSIFVL HHHHHHHHCCEEEEE | 25.63 | - | |
691 | Phosphorylation | ITCIEKSYKSIFVLS HHHHHHHCCEEEEEC | 21.59 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TLR1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TLR1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TLR1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TLR2_HUMAN | TLR2 | physical | 12077222 | |
TLR6_HUMAN | TLR6 | physical | 28514442 | |
A16A1_HUMAN | ALDH16A1 | physical | 28514442 | |
DEOC_HUMAN | DERA | physical | 28514442 | |
CNPY3_HUMAN | CNPY3 | physical | 28514442 | |
TBC24_HUMAN | TBC1D24 | physical | 28514442 | |
TM214_HUMAN | TMEM214 | physical | 28514442 | |
PLXB2_HUMAN | PLXNB2 | physical | 28514442 | |
MAVS_HUMAN | MAVS | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00344 | Leprosy; Hansen disease | |||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Crystal structure of the TLR1-TLR2 heterodimer induced by binding ofa tri-acylated lipopeptide."; Jin M.S., Kim S.E., Heo J.Y., Lee M.E., Kim H.M., Paik S.-G., Lee H.,Lee J.-O.; Cell 130:1071-1082(2007). Cited for: X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 25-476 IN COMPLEX WITH TLR1AND BACTERIAL LIPOPEPTIDE ANALOG, DISULFIDE BONDS, AND GLYCOSYLATIONAT ASN-51; ASN-163; ASN-330 AND ASN-429. | |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-163, AND MASSSPECTROMETRY. |